MACK DAVID J.
Insider CIK 1694466 · GLBL Director · BTAI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-10-31 | 2025-11-03 | 1,694 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-10-31 | 2025-11-03 | 1,694 | — | $0 | 20,317 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-09-30 | 2025-10-01 | 1,694 | — | $0 | 1,694 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-09-30 | 2025-10-01 | 1,694 | — | $0 | 18,623 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-08-31 | 2025-09-02 | 1,693 | — | $0 | 3,387 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-08-31 | 2025-09-02 | 1,693 | — | $0 | 16,930 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-07-31 | 2025-07-31 | 1,693 | — | $0 | 5,080 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-07-31 | 2025-07-31 | 1,693 | — | $0 | 15,237 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-06-30 | 2025-06-30 | 1,693 | — | $0 | 6,773 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-06-30 | 2025-06-30 | 1,693 | — | $0 | 13,544 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-05-31 | 2025-06-02 | 1,693 | — | $0 | 8,466 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-05-31 | 2025-06-02 | 1,693 | — | $0 | 11,851 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-04-30 | 2025-05-01 | 1,693 | — | $0 | 10,159 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-04-30 | 2025-05-01 | 1,693 | — | $0 | 10,158 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-03-31 | 2025-04-01 | 1,693 | — | $0 | 11,852 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-03-31 | 2025-04-01 | 1,693 | — | $0 | 8,465 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-02-28 | 2025-03-04 | 1,693 | — | $0 | 13,545 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-02-28 | 2025-03-04 | 1,693 | — | $0 | 6,772 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 27,089 | — | $0 | 243,810 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 27,089 | — | $0 | 81,267 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 27,089 | — | $0 | 270,899 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 27,089 | — | $0 | 54,178 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-11-30 | 2024-12-04 | 27,089 | — | $0 | 297,988 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-11-30 | 2024-12-03 | 27,089 | — | $0 | 27,089 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-11-30 | 2024-12-04 | 27,089 | — | $0 | 27,089 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-11-21 | 2024-11-25 | 325,077 | — | $0 | 325,077 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-11-21 | 2024-12-03 | 297,988 | — | $0 | 297,998 | SEC↗ |
| GLBL TERRAFORM GLOBAL, INC. | D To issuer deriv | 2017-12-28 | 2018-01-02 | 55,419 | $5.10 | $282.6K | 12,081 | SEC↗ |
| GLBL TERRAFORM GLOBAL, INC. | J Other deriv | 2017-12-28 | 2018-01-02 | 12,081 | — | $0 | 0 | SEC↗ |
| GLBL TERRAFORM GLOBAL, INC. | A Award deriv | 2017-08-04 | 2017-08-08 | 30,000 | — | $0 | 67,500 | SEC↗ |
| GLBL TERRAFORM GLOBAL, INC. | A Award deriv | 2017-01-04 | 2017-01-13 | 37,500 | — | $0 | 37,500 | SEC↗ |